Aligos Therapeutics Presents Clinical Data from NASH Program at the 2023 Paris Hepatology Conference

SOUTH SAN FRANCISCO, Calif., March 29, 2023 -- Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in... | March 29, 2023

Related Keywords

Paris ,France General ,France ,Russia ,Ukraine ,Lawrence Blatt ,Amy Jobe ,Mattheww Mcclure ,Corey Davis ,Aligos Therapeutics Inc ,Exchange Commission ,Nasdaq ,Exchange Commission On ,Lifesci Communications ,Paris Hepatology Conference ,Scientific Presentations ,Favorable Safety ,Pharmacokinetic Profile ,Dose Proportionally Lowers Lipid Biomarkers ,Chief Medical Officer ,Drugs Pipeline Presented ,Securities Litigation Reform Act ,Aligo Annual Report ,Aligos Therapeutics ,Nc Stock Exchange ,News ,Information ,Press Release ,Mouth ,Han ,Arch ,023 ,Aligos ,Linical ,Stage ,Iopharmaceutical ,Company ,Ocused ,N ,Developing ,Novel ,Herapeutics ,O ,Address ,Unmet ,Medical ,Eeds Algs Us01626l1052 ,